Rekah Pharmaceutical Industry Ltd.
TLV: REKA.TA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tel Aviv Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mordechai Elgrabli
- Employees
- 421
- Headquarters
- Holon, Israel
- IPO year
- 2002
- Market cap
- ILA 126.5M
- Website
- https://www.rekah.co.il
Loading REKA…
Loading profile data…Frequently asked questions about REKA
What does Rekah Pharmaceutical Industry Ltd. (REKA.TA) do?
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness...
Where does REKA.TA trade?
Rekah Pharmaceutical Industry Ltd. (REKA.TA) trades on the Tel Aviv Stock Exchange.
What sector is REKA.TA in?
Rekah Pharmaceutical Industry Ltd. (REKA.TA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Rekah Pharmaceutical Industry Ltd.?
Mordechai Elgrabli is the chief executive officer of Rekah Pharmaceutical Industry Ltd. (REKA.TA).
Where is Rekah Pharmaceutical Industry Ltd. headquartered?
Rekah Pharmaceutical Industry Ltd. is headquartered in Israel.
Does REKA.TA pay a dividend?
Rekah Pharmaceutical Industry Ltd. (REKA.TA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did REKA.TA go public?
Rekah Pharmaceutical Industry Ltd. (REKA.TA) completed its initial public offering in 2002.